On May 20, 2010
The Little Company That Couldn’t: Why No One Cares About MannKind’s Potential Diabetes Blockbuster
Does MannKind actually have data showing an advantage over other drugs in lowering blood glucose levels? And why hasn’t MannKind been able to sign up a Big Pharma partner with the global resources to market this product into a blockbuster?
…
0 Comments